PharmaGuide Weekly. Medication recalls FDA posted November 9, 2026 to November 15, 2026. Each recall covers only the products and lots in its record, not every product with the same active ingredient.
This week at a glance
Most serious first, by FDA's recall class; class I is the most serious. If you have one of these, find the lot number on its label or box and check it against the card.
FDA, Recalls Background and Definitions: fda.gov/safety/industry-guidance-recalls/recalls-background-and-definitions
- Eugia Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial): Eugia US LLC
- Famotidine Injection, 200 mg per 50 mL (4 mg per mL), 1 x 50 mL Multi-Dose Vial, For Intravenous Use: Sagent Pharmaceuticals · Not Yet Classified
- Glutathione 200mg/mL (pf) Injection Solution: Premium Health Care LLC · Not Yet Classified
- Fludrocortisone Acetate Tablets, USP 0.1mg: AvKARE · Class II
- Dextrose Low Magnesium Low Calcium and Attached stay safe Exchange Set (5 products): Fresenius Medical Care Renal Therapies Group, LLC · Class II
- Ciprofloxacin Tablets, USP (2 products): Hikma Pharmaceuticals USA INC. · Class II
- Tychasis Coats Aloe (3 products): BioMed Laboratories, LLC. · Class II
- Artificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0: Preferred Pharmaceuticals, Inc. · Class II
- VMC Victory Medical Center Pharmacy Austin Texas (42 products): Victory Medical Center Pharmacy · Class II
- Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle: Advagen Pharma Limited · Class II
- Cyanocobalamin Injection, USP, 1,000 mcg/mL: American Health Packaging · Class II
New recalls
Company notices on FDA's recalls page.
Recall · Announced November 6, 2026
Eugia Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial)
Recalled by Eugia US LLC
What to do
Read the official notice for what to do.
Why: Presence of particulate matter identified as a glass particle inside the vial
Products and lots in the notice
- November 06,2026 – East Windsor, New Jersey, Eugia US LLC (f/k/a Auro Medics Pharma LLC) is voluntarily recalling lot number 3VM26026A of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) to the hospital/healthcare facility/user level due to the presence of particulate matter identified as a glass particle inside the vial.
- The recalled product is packaged in 30 mL vial and packed as 10 (vials) X 10 (Printed cartons) X 01 (Shipper) with NDC code as 55150-471-01.
- The product can be identified by product name on carton (NDC 55150-471-10) and vial (NDC 55150-471-01) label and with lot number 3VM26026A and Exp. JUL 2028
- Eugia US LLC shipped the entire lot to wholesalers nationwide from September 2, 2026, through September 15, 2026.
- Wholesalers/hospitals/pharmacies, institutions, and doctors with existing inventory of the recalled product lot should discontinue use and quarantine the product immediately.
- If you have further distributed the recalled product lot, please notify your accounts and or any additional locations which may have received the recalled product.
Refunds, questions and health concerns (from the notice):
- Consumers with medical questions regarding this recall or reporting an adverse event can contact Eugia US LLC from 8:00 am to 5:00 p.m.
- Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Tablets, liquids, creams and other products: newly listed by FDA
From FDA's Enforcement Report for November 11, 2026, most serious first. Unless a card links a company notice, we found none on FDA's recalls page, so the card cites the Enforcement Report.
FDA recall listing · Listed November 11, 2026
Fludrocortisone Acetate Tablets, USP 0.1mg
Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK, Manufactured for: AvKARE, Pulaski, TN 38748, NDC 50268-330-15
Recalled by AvKARE
Class IIMay cause temporary or medically reversible health problems; serious harm is unlikely
What to do
Check your lot number against the lots listed below. FDA says consumers can generally continue taking the medicine unless the recalling company provides other instructions. Ask your doctor or pharmacist if you have questions.
Why: Failed Impurities/Degradation Specifications
Check your package: Lot # 48353; Exp. 10/31/2026
Where it was sold: U.S. Nationwide
The company started this recall voluntarily on October 9, 2026. FDA Event ID 100126.
FDA recall listing · Listed November 11, 2026
Dextrose Low Magnesium Low Calcium and Attached stay safe Exchange Set (5 products)
Products include DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose; DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose; DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose.
Recalled by Fresenius Medical Care Renal Therapies Group, LLC
Class IIMay cause temporary or medically reversible health problems; serious harm is unlikely
What to do
Check your lot number against the lots listed below. FDA says consumers can generally continue taking the medicine unless the recalling company provides other instructions. Ask your doctor or pharmacist if you have questions.
Why: Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Check your package
| Product | Lot numbers and codes |
|---|---|
| DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,000 mL - Single Dose Bag, Sterile and Non-Pyrogenic, Rx only, CAT.NO. 054-20221. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-206-92 | Lot #: 25JGPD045, Lot 25JGPD046, Lot 25JGPD060, Exp 1/31/2027; 25KGPD057, Exp 2/28/2027. |
| DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,000 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. No. 054-20222. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-209-92 | Lot # 25DGPD002, 25DGPD003, Exp 10/31/2026; 25KGPD027, 25KGPD042, Exp 2/28/2027; 25SGPD033, Exp 6/30/2027; 26AGPD033, 26AGPD054, Exp 7/31/2027. |
| DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. NO. 054-25321. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-206-94 | Lot#: 25HGPD037, Exp 12/31/2026; 26CGPD074, Exp 9/30/2027. |
| DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay"safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT. NO. 054-25322. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-209-94 | Lot#: 25JGPD069, Exp 1/31/2027; 25SGPD046, 25SGPD059, 25SGPD063, Exp 6/30/2027; 26EGPD022, Exp 11/30/2027. |
| DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT.NO. 054-25324. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-212-94 | Lot: 25NGPD001, Exp 4/30/2027 |
Where it was sold: Nationwide in the USA.
The company started this recall voluntarily on October 14, 2026. FDA Event ID 100130.
FDA recall listing · Listed November 11, 2026
Ciprofloxacin Tablets, USP (2 products)
Recalled by Hikma Pharmaceuticals USA INC.
Class IIMay cause temporary or medically reversible health problems; serious harm is unlikely
What to do
Check your lot number against the lots listed below. FDA says consumers can generally continue taking the medicine unless the recalling company provides other instructions. Ask your doctor or pharmacist if you have questions.
Why: CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Check your package
| Product | Lot numbers and codes |
|---|---|
| Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01 | Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026 |
| Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50 | Lot# CA083A Exp. 12/31/2026 Lot# CA084A Exp. 12/31/2026 Lot# CA085A Exp. 12/31/2026 |
Where it was sold: US Nationwide
The company started this recall voluntarily on October 20, 2026. FDA Event ID 100142.
FDA recall listing · Listed November 11, 2026
Tychasis Coats Aloe (3 products)
Products include Tychasis Coats Aloe Lotion (Allantoin 0.5%) packaged in a)0.5 oz; Tychasis Coats Aloe Creme (Allantoin 0.5%); Tychasis Coats Aloe Liniment (Methyl salicylate 10%).
Recalled by BioMed Laboratories, LLC.
Class IIMay cause temporary or medically reversible health problems; serious harm is unlikely
What to do
Check your lot number against the lots listed below. FDA says consumers can generally continue taking the medicine unless the recalling company provides other instructions. Ask your doctor or pharmacist if you have questions.
Why: Failed Stability Specifications: OOS stability results included viscosity and appearance results that did not align with the established specifications.
Check your package
| Product | Lot numbers and codes |
|---|---|
| Tychasis Coats Aloe Lotion (Allantoin 0.5%) packaged in a)0.5 oz, b)8 oz (NDC 70211-704-08), and c)33 oz (NDC 70211-704-33) bottles, Manufactured for: Tychasis Corporation, Dallas, TX 75227. There is no NDC for the 0.5 oz given that it is a sample size used as a professional sample. | Lot #:a) 011636, Exp. Date Nov-30-2026; b) 0001882604, Exp. Date Aug-31-2027; 0001987649, Exp. Date Apr-30-2028; 008943, Exp. Date Nov-30-2026; c) 0001893936, Exp. Date Aug-31-2027 |
| Tychasis Coats Aloe Creme (Allantoin 0.5%), packaged in a) 4oz (NDC 70211-703-04), and b)16 oz (NDC 70211-703-16) jars, Manufactured for: Tychasis Corporation, Dallas, TX 75227. | Lot #: a)0002011787,0001932354, Exp. Date Apr-30-2027; b) 0002049590, Exp. Date Apr-30-2027 |
| Tychasis Coats Aloe Liniment (Methyl salicylate 10%), packaged a) 0.5 oz, b) 8 oz (NDC 70211-704-08) c) 33oz (NDC 70211-704-33) bottles, Manufactured for: Tychasis Corporation, Dallas, TX 75227. There is no NDC for the 0.5 oz given that it is a sample size used as a professional sample. | Lot #: a)0.5 oz 0001882607, Exp. Date Jul-31-2027; b) 0001882605, 0001916439 Exp. Date Jul-31-2027; c) Lot #: 0001882606, Exp. Date Jul-31-2027 |
Where it was sold: TX only
The company started this recall voluntarily on October 15, 2026. FDA Event ID 100153.
FDA recall listing · Listed November 11, 2026
Artificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0
Recalled by Preferred Pharmaceuticals, Inc.
Class IIMay cause temporary or medically reversible health problems; serious harm is unlikely
What to do
Check your lot number against the lots listed below. FDA says consumers can generally continue taking the medicine unless the recalling company provides other instructions. Ask your doctor or pharmacist if you have questions.
Why: Lack of Assurance of Sterility
Check your package: Lot C2825L,Exp 2/28/2027 Lot G1825U,Exp 5/28/2027 Lot D0826A,Exp 11/30/2027 Lot D1326B,Exp 11/30/2027
Where it was sold: U.S. Nationwide
The company started this recall voluntarily on October 16, 2026. FDA Event ID 100159.
FDA recall listing · Listed November 11, 2026
VMC Victory Medical Center Pharmacy Austin Texas (42 products)
Products include ALPHA LIPOIC ACID (MDV) 25MG/ML **30ML**; ASCORBIC ACID (MDV) 500MG/ML **50ML**; ASCORBIC ACID (PRESERVATIVE FREE) 500MG/ML **50ML**; B COMPLEX (MDV) **30ML**; BIOTIN 10MG/ML (MDV) **30ML**; and more.
Recalled by Victory Medical Center Pharmacy
Class IIMay cause temporary or medically reversible health problems; serious harm is unlikely
What to do
Check your lot number against the lots listed below. FDA says consumers can generally continue taking the medicine unless the recalling company provides other instructions. Ask your doctor or pharmacist if you have questions.
Why: Lack of Processing Controls
Check your package
| Product | Lot numbers and codes |
|---|---|
| ALPHA LIPOIC ACID (MDV) 25MG/ML **30ML**, VMC, Victory Medical Center Pharmacy, Austin Texas | Lot, expiry: Lot 2051563, exp 10/24/2026 |
| ASCORBIC ACID (MDV) 500MG/ML **50ML**, VMC, Victory Medical Center Pharmacy, Austin Texas | Lot, expiry: Lot 2022189 , exp 10/20/2026; Lot 2033408 , exp 11/2/2026; Lot 2066714 , exp 11/15/2026 |
| ASCORBIC ACID (PRESERVATIVE FREE) 500MG/ML **50ML**, VMC, Victory Medical Center Pharmacy, Austin Texas | Lot, expiry: Lot 2021088 , exp 10/19/2026 |
| B COMPLEX (MDV) **30ML**, VMC, Victory Medical Center Pharmacy, Austin Texas | Lot, expiry: Lot 1997277 , exp 11/16/2026 ; Lot 2011266 , exp 12/1/2026; |
| BIOTIN 10MG/ML (MDV) **30ML**, VMC, Victory Medical Center Pharmacy, Austin Texas | Lot, expiry: Lot 2039612 , exp 11/9/2026 |
| BPC-157 (MDV) 5MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin Texas | Lot, expiry: Lot 2031940 , exp 10/30/2026 |
| BPC-157/KPV 5/5MG/ML (MDV) **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2040622 , exp 11/9/2026 |
| BPC-157/THYMOSIN BETA-4 (MDV) 5/5MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2024434 , exp 10/22/2026; Lot 2052871 , exp 10/25/2026 |
| CAGRILINTIDE/GLYCINE/B12 (MDV) 3.75/5/1MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2021027 , exp 10/19/2026 |
| CJC-1295 (MDV) 2MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2024280 , exp 10/22/2026 |
| CJC-1295/IPAMORELIN (MDV) 2/2MG/ML **2ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2033410 , exp 10/30/2026 |
| CJC-1295/IPAMORELIN (MDV) 2/2MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2030999 , exp 10/30/2026; Lot 2060091 , exp 11/3/2026 |
| DEXAMETHASONE PHOSPHATE (MDV) 24MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 1953348 , exp 10/21/2026; Lot 2071537 , exp 11/2/2026 |
| DEXPANTHENOL (MDV) 250MG/ML **30ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2030273 , exp 10/29/2026 |
| ELECTRO B COMPLEX (MDV) **49ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2051805 , exp 10/21/2026 ; Lot 2056424 , exp 10/21/2026 ; Lot 2037324 , exp 11/4/2026 ; Lot 2061823 , exp 11/4/2026 ; Lot 2062515 , exp 11/8/2026 ; Lot 2066019 , exp 11/14/2026 ; Lot 2067626 , exp 11/15/2026 ; Lot 2068726 , exp 11/16/2026 ; Lot 2069972 , exp 11/19/2026 ; Lot 2071364 , exp 11/21/2026 |
| GHK- CU (MDV) 10MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2040433 , exp 11/3/2026 |
| HYDROXOCOBALAMIN **MDV** 1MG/ML (30ML), VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2023206 , exp 10/21/2026 |
| L-CARNITINE 500MG/ML (MDV) **30ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2027778 , exp 10/27/2026 |
| METHYL MIX (MDV) 6.25/6.25/5/6.25MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2031123 , exp 11/14/2026 |
| METHYLCOBALAMIN (MDV) 1MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2052620 , exp 10/25/2026 |
| METHYLCOBALAMIN 12.5MG/ML (MDV) **30ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 1994005 , exp 12/13/2026 |
| METHYLCOBALAMIN 1MG/ML (MDV) **30ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2064355 , exp 11/10/2026; Lot 1981816 , exp 11/29/2026 |
| METHYLCOBALAMIN 5MG/ML (MDV) **30ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2056976 , exp 10/31/2026; Lot 1981289 , exp 11/29/2026 Lot 2008532 , exp 12/30/2026 ; Lot 2027811 , exp 1/25/2027 |
| MPT-141/NIACINAMIDE 50/2MG/ML (MDV) **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2054825 , exp 10/27/2026; Lot 2072131 , exp 11/22/2026 |
| NAD+ 400MG/ML (MDV) **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2025183 , exp 10/23/2026 |
| SEMAGLUTIDE/L-CARNITINE 2.5/25MG/ML **1ML** MDV, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2025026 , exp 10/19/2026; Lot 2028871 , exp 10/28/2026 |
| SEMAGLUTIDE/L-CARNITINE 5/50MG/ML (1ML MDV), VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2039511 , exp 11/2/2026 |
| SEMAGLUTIDE/L-CARNITINE 5/50MG/ML (3ML MDV), VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2039510 , exp 11/2/2026; Lot 2059744 , exp 11/3/2026 |
| TAURINE (MDV) 50MG/ML **30ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2044254 , exp 11/11/2026 |
| TESAMORELIN (MDV) 10MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2032646 , exp 11/2/2026 |
| TESAMORELIN/IPAMORELIN (MDV) 5MG/2MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2026301 , exp 10/23/2026 |
| THYMOSIN ALPHA-1 (MDV) 3MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2033588 , exp 11/3/2026; Lot 2044847 , exp 11/13/2026 |
| THYMOSIN BETA-500 (MDV) 10MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2032275 , exp 10/30/2026 |
| TIRZEPATIDE/B6 (MDV) 25MG/10MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2012330 , exp 10/24/2026 |
| TIRZEPATIDE/B6 (MDV) 25MG/10MG/ML **8ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2012787 , exp 10/24/2026 |
| TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2054678 , exp 10/27/2026 |
| TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2053172 , exp 10/24/2026; Lot 2028876 , exp 10/27/2026; Lot 2060129 , exp 11/3/2026 |
| TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML **8ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2027785 , exp 10/27/2026; Lot 2040537 , exp 11/2/2026; Lot 2059733 , exp 11/3/2026 |
| TIRZEPATIDE/L-CARNITINE **10/50MG/ML** (MDV) **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2024992 , exp 10/20/2026; Lot 2058102 , exp 11/1/2026 |
| TIRZEPATIDE/L-CARNITINE 30/100MG/ML (MDV) **2ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2060378 , exp 11/4/2026 |
| TIRZEPATIDE/NIACINAMIDE (MDV) 20/2MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2025319 , exp 10/23/2026; Lot 2064762 , exp 11/11/2026; Lot 2049664 , exp 11/19/2026 |
| ZINC SULFATE (MDV) 10MG/ML **30ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas | Lot, expiry: Lot 2057631 , exp 11/1/2026 |
Where it was sold: CO, FL, TX
The company started this recall voluntarily on October 19, 2026. FDA Event ID 100168.
FDA recall listing · Listed November 11, 2026
Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle
Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00.
Recalled by Advagen Pharma Limited
Class IIMay cause temporary or medically reversible health problems; serious harm is unlikely
What to do
Check your lot number against the lots listed below. FDA says consumers can generally continue taking the medicine unless the recalling company provides other instructions. Ask your doctor or pharmacist if you have questions.
Why: Presence of Foreign Tablets/Capsules
Check your package: Batch#: 2611C065A1: Expiry: 05/2028
Where it was sold: U.S. Nationwide
The company started this recall voluntarily on October 27, 2026. FDA Event ID 100234.
Injections and IV products: newly listed by FDA
From FDA's Enforcement Report for November 11, 2026, most serious first. Unless a card links a company notice, we found none on FDA's recalls page, so the card cites the Enforcement Report.
FDA recall listing · Listed November 11, 2026
Famotidine Injection, 200 mg per 50 mL (4 mg per mL), 1 x 50 mL Multi-Dose Vial, For Intravenous Use
Rx only, Sterile, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60173. NDC: 25021-756-50
Recalled by Sagent Pharmaceuticals
Not Yet ClassifiedFDA has not rated this recall's risk yet
What to do
Check your lot number against the lots listed below. FDA has not rated this recall yet and the Enforcement Report gives no patient instructions. Ask your doctor or pharmacist if you have this lot.
Why: Presence of Particulate Matter
Check your package: Lot# E243A001; Exp. 02/28/2027
Where it was sold: US Nationwide
The company started this recall voluntarily on October 22, 2026. FDA Event ID 100208.
FDA recall listing · Listed November 11, 2026
Cyanocobalamin Injection, USP, 1,000 mcg/mL
Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent, Inc., For Bluepoint Laboratories. Carton NDC 68001-542-60; Vial NDC 68001-542-59
Recalled by American Health Packaging
Class IIMay cause temporary or medically reversible health problems; serious harm is unlikely
What to do
Check your lot number against the lots listed below. FDA says consumers can generally continue taking the medicine unless the recalling company provides other instructions. Ask your doctor or pharmacist if you have questions.
Why: Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.
Check your package: Lot: 24394A, Exp 10-31-2026
Where it was sold: Nationwide in the USA
The company started this recall voluntarily on October 22, 2026. FDA Event ID 100204.
A recall is about specific lots, not a whole medicine. To see how PharmaGuide checks a supplement against the medications you take, read how it works. More safety posts are on the blog.
Sources
- How we check: FDA's recalls page and every Enforcement Report in the week; a recall is included when FDA files it under drugs. Veterinary products are left out, and supplements have their own weekly post. A notice FDA files under another category appears here once the Enforcement Report lists it.
- FDA: Understanding Drug Recalls: What to Know and What to Do
- FDA: Recalls, Market Withdrawals & Safety Alerts
- FDA: Enforcement Reports
- Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter